Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)Michele M. Corsini, Leonard L. Gunderson, Robert C. Miller et al.|Journal of Clinical Oncology|2008Cited by 270
A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumabTimothy J. Poterucha, Aminah Jatoi, Brian L. Burnette|Medical Oncology|2011Cited by 27
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic MalignanciesEleftheria Kalogera, Matthew S. Block, Aminah Jatoi et al.|Clinical Cancer Research|2024Cited by 15
A phase I trial of Nab-Paclitaxel/Bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707) (1308)Matthew S. Block, Svetomir N. Markovic, Eleftheria Kalogera et al.|Gynecologic Oncology|2023Cited by 1
Supplementary Table S1 from A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic MalignanciesEleftheria Kalogera, Matthew S. Block, Wendy K. Nevala et al.|Unknown|2024Cited by 0